LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 50.33 | 17.25 | 3287 | 4651 | 0.7067 | 0.9158 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 50.33 | 17.25 | 5828 | 4651 | 1.2530 | 1.0567 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 52.30 | 17.25 | 3 | 4798 | 0.0006 | -0.1938 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 52.30 | 17.25 | 4617 | 4798 | 0.9622 | 0.9905 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 52.30 | 17.25 | 2865 | 4798 | 0.5971 | 0.8769 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 52.30 | 17.25 | 6221 | 4798 | 1.2964 | 1.0650 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 54.27 | 17.25 | 4 | 4884 | 0.0008 | -0.1643 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 54.27 | 17.25 | 4933 | 4884 | 1.0100 | 1.0024 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 54.27 | 17.25 | 2813 | 4884 | 0.5760 | 0.8690 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 54.27 | 17.25 | 6637 | 4884 | 1.3589 | 1.0767 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 56.24 | 17.25 | 2 | 4929 | 0.0004 | -0.2321 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 56.24 | 17.25 | 5304 | 4929 | 1.0761 | 1.0181 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 56.24 | 17.25 | 1867 | 4929 | 0.3788 | 0.7756 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 56.24 | 17.25 | 7121 | 4929 | 1.4447 | 1.0923 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 58.21 | 17.25 | 3 | 4942 | 0.0006 | -0.1929 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 58.21 | 17.25 | 5647 | 4942 | 1.1426 | 1.0329 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 58.21 | 17.25 | 1379 | 4942 | 0.2790 | 0.7105 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 58.21 | 17.25 | 7562 | 4942 | 1.5300 | 1.1070 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 60.18 | 17.25 | 1 | 5031 | 0.0002 | -0.2938 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 60.18 | 17.25 | 5966 | 5031 | 1.1857 | 1.0420 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 60.18 | 17.25 | 1208 | 5031 | 0.2401 | 0.6802 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 60.18 | 17.25 | 8038 | 5031 | 1.5975 | 1.1178 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 63.15 | 17.25 | 2 | 5061 | 0.0004 | -0.2312 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 63.15 | 17.25 | 6330 | 5061 | 1.2507 | 1.0553 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 63.15 | 17.25 | 825 | 5061 | 0.1630 | 0.6029 | MN20160310_N02 | N08 |